1. Real‐world weight change among patients treated with glucagon‐like peptide‐1 receptor agonist, dipeptidyl peptidase‐4 inhibitor and sulfonylureas for type 2 diabetes and the influence of medication adherence. (20th July 2017) Authors: Carls, G. S.; Tan, R.; Zhu, J. Y.; Tuttle, E.; Yee, J.; Edelman, S. V.; Polonsky, W. H. Journal: Obesity science and practice Issue: Volume 3:Number 3(2017) Page Start: 342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗